BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18208949)

  • 1. Trastuzumab treatment for breast cancer during pregnancy.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Can Fam Physician; 2008 Jan; 54(1):31-2. PubMed ID: 18208949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab use for metastatic breast cancer in pregnancy.
    Sekar R; Stone PR
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Reprod Toxicol; 2007 Jun; 23(4):611-3. PubMed ID: 17399946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
    Beale JM; Tuohy J; McDowell SJ
    Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
    Watson WJ
    Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
    Mir O; Berveiller P; Ropert S; Goffinet F; Pons G; Treluyer JM; Goldwasser F
    Ann Oncol; 2008 Apr; 19(4):607-13. PubMed ID: 17921242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
    Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
    Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
    [No Abstract]   [Full Text] [Related]  

  • 8. Trastuzumab administration during pregnancy: a systematic review and meta-analysis.
    Zagouri F; Sergentanis TN; Chrysikos D; Papadimitriou CA; Dimopoulos MA; Bartsch R
    Breast Cancer Res Treat; 2013 Jan; 137(2):349-57. PubMed ID: 23242615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adjuvant trastuzumab on pregnancy.
    Waterston AM; Graham J
    J Clin Oncol; 2006 Jan; 24(2):321-2. PubMed ID: 16401684
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case Report on Treatment of Metastatic Breast Cancer with Trastuzumab during Pregnancy].
    Rasenack R; Gaupp N; Rautenberg B; Stickeler E; Prömpeler H
    Z Geburtshilfe Neonatol; 2016 Apr; 220(2):81-3. PubMed ID: 27111595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab in pregnancy associated with poor fetal outcome.
    Witzel ID; Müller V; Harps E; Janicke F; Dewit M
    Ann Oncol; 2008 Jan; 19(1):191-2. PubMed ID: 18084047
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
    Fanale MA; Uyei AR; Theriault RL; Adam K; Thompson RA
    Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of breast cancer with trastuzumab during pregnancy.
    Pant S; Landon MB; Blumenfeld M; Farrar W; Shapiro CL
    J Clin Oncol; 2008 Mar; 26(9):1567-9. PubMed ID: 18349415
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of pertuzumab and trastuzumab during pregnancy.
    Yildirim N; Bahceci A
    Anticancer Drugs; 2018 Sep; 29(8):810-813. PubMed ID: 30110018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis.
    Xia LY; Hu QL; Zhou Q
    BMC Womens Health; 2021 Apr; 21(1):169. PubMed ID: 33882925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
    Azim HA; Metzger-Filho O; de Azambuja E; Loibl S; Focant F; Gresko E; Arfi M; Piccart-Gebhart M
    Breast Cancer Res Treat; 2012 May; 133(1):387-91. PubMed ID: 22367645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic pregnancy in a breast cancer patient receiving trastuzumab.
    Berveiller P; Mir O; Sauvanet E; Antoine EC; Goldwasser F
    Reprod Toxicol; 2008 Feb; 25(2):286-8. PubMed ID: 18201867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
    Mandrawa CL; Stewart J; Fabinyi GC; Walker SP
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):372-6. PubMed ID: 21806575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trastuzamab (Herceptin)-related cardiotoxicity in pregnancy.
    Roberts NJ; Auld BJ
    J R Soc Med; 2010 Apr; 103(4):157-9. PubMed ID: 20382907
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuation of trastuzumab beyond disease progression.
    Montemurro F; Faggiuolo R; Redana S; Donadio M; Minischetti M; Durando A; Vietti-Ramus G; Buosi R; Aglietta M
    J Clin Oncol; 2005 Apr; 23(12):2866-8; discussion 2868-9. PubMed ID: 15838006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.